Recommendations for Investigational Use of COVID-19 Convalescent Plasma

Food and Drug Administration. (2020). Recommendations for Investigational Use of COVID-19 Convalescent Plasma. U.S. Department of Health and Human Services.
This page includes guidance on the administration and study of investigational COVID-19 convalescent plasma. It includes pathways for use, information on collection of convalescent plasma, labeling, and recordkeeping.
Rate: Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.